Enzyme-mediated synthesis of EEHP and EMHP, useful pharmaceutical intermediates of PPAR agonists

Tetrahedron Asymmetry

Volumn 20, Issue 22, 2009, Pages 2594-2599

  Brenna, Elisabetta ^a   Fuganti, Claudio ^a   Gatti, Francesco G ^a   Parmeggiani, Fabio ^a  

^a POLITECNICO DI MILANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN A; ESTER DERIVATIVE; ETHYL 2 ETHOXY 3 (4 HYDROXYPHENYL)PROPANOIC ACID; ETHYL 2 METHOXY 3 (4 HYDROXYPHENYL)PROPANOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PROPIONIC ACID DERIVATIVE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ACYLATION; ALKYLATION; ARTICLE; ASYMMETRIC SYNTHESIS; CATALYSIS; ENZYME CHEMISTRY; PRIORITY JOURNAL; RACEMIC MIXTURE;

EID: 72049098523     PISSN: 09574166     EISSN: 1362511X     Source Type: Journal    
DOI: 10.1016/j.tetasy.2009.10.013     Document Type: Article

References (27)

1. For a review see:. Balakumar P., Rose M., Ganti S.S., Krishan P., and Singh M. Pharm. Res. 56 (2007) 91
2. Anderson, K. PCT Appl. WO 99/62872 (1999 to Astra).
3. Martin J.A., Brooks D.A., Prieto L., Gonzalez R., Torrado A., Rojo I., Lopez de Uralde B., Lamas C., Ferrito M., Martin-Ortega M.D., Agejas J., Parra F., Rizzo J.R., Rhodes G.A., Robey R.L., Alt C.A., Wendel S.R., Zhang T.Y., Reifel-Miller A., Montrose-Rafidazeh C., Brozinik J.T., Hawkins E., Misener E.A., Briere D.A., Ardecky R., Fraser J.D., and Warshawsky A.M. Bioorg. Med. Chem. Lett. 15 (2005) 51-55
4. ® by AstraZeneca, but its production was stopped in 2006, because the benefits were not worth the risks.
5. Parmenon C., Guillard J., Caignard D.-H., Hennuyer N., Staels B., Audinot-Bouchez V., Boutin J.A., Dacquet C., Ktorza A., and Viaud-Massuard M.-C. Bioorg. Med. Chem. Lett. 18 (2008) 1617
6. For an approach based on the diazotisation of l-tyrosine derivatives, followed by O-alkylation see: Potlapally, R. K.; Siripragada, M. R.; Kotra, N. M.; Sirisilla, R.; Mamillapalli, R. S.; PCT Appl. WO 02/24625.
7. Potlapally, R. K.; Siripragada, M. R.; Mamillapalli, R. S.; Gaddam, O. R.; Jangaigar, T. R.; Velagala, V. R. M. K. R.; PCT Appl. WO 03/027084.
8. Zeng Q.L., Wang H.Q., Liu Z.R., Li B.G., and Zhao Y.F. Amino Acids 33 (2007) 536-541
9. For an approach based on enzymatic/chemical resolution of derivatives of 1 or 2, see:. Deussen H.-J., Zundel M., Valdois M., Lehmann S.V., Weil V., Hjort C.M., Østergaard P.R., Marcussen E., and Ebdrup S. Org. Process Res. Dev. 7 (2003) 82-88
10. Linderberg M.T., Moge M., and Sivadasan S. Org. Process Res. Dev. 8 (2004) 838-845
11. Ebdrup, S.; Deussen, H.-J.; Zundel, M.; Bury, P. S.; PCT Appl. WO 01/11073.
12. For an asymmetric synthesis of 1 by catalytic reduction of α-ethoxycinnamic acid, see: Woltering, M.; Bunlakasnanusorn, T.; Gerlach, A. PCT Appl. US 2007/0149804.
13. Houpis I.N., Patterson L.E., Alt C.A., Zhang T.Y., and Haurez M. Org. Lett. 7 (2005) 1947-1950
14. Brenna, E.; Fuganti, C.; Gatti, F. C.; Parmeggiani, F. Tetrahedron: Asymmetry 2009, 20, in press. doi:10.1016/j.tetasy.2009.09.024.
15. Wang Z., La B., Fortunak J.M., Meng X.-J., and Kabalka G.W. Tetrahedron Lett. 39 (1998) 5501-5504
16. Sundholm O., and Kanerva L.T. ACH-Models Chem. 135 (1998) 625-640
17. Baskar B., Pandian N.G., Priya K., and Chadha A. Tetrahedron 61 (2005) 12296-12306
18. Gentile A., Giordano C., Fuganti C., Ghirotto L., and Servi S. J. Org. Chem. 57 (1992) 6635-6637
19. Barot, V. K. G.; Kothari, H. M.; Lohray, B. B.; Lohray, V. B. PCT Appl. WO 2005/019152.
20. Rizzo J.R., and Zhang T.Y. Chimia 9 (2006) 580-583
21. A similar PS-lipase-mediated resolution has been already carried out on the methyl ester of 5, Ref. 9b.
22. Yamano T., Kikumoto F., Yamamoto S., Miwa K., Kawada M., Ito T., Ikemoto T., Tomimatsu K., and Mizuno Y. Chem. Lett. 29 (2000) 448-450
23. Koga K., Wu C.C., and Yamada S.-I. Chem. Pharm. Bull. 20 (1972) 1272
24. Cohen S.G., and Weinstein S.Y. J. Am. Chem. Soc. 86 (1964) 5326-5330
25. Aikins J.A., Haurez M., Rizzo J.R., Van Hoeck J.-P., Brione W., Kastemont J.-P., Stevens C., Lemair X., Stephenson G.A., Marlot E., Forst M., and Houpis I.N. J. Org. Chem. 70 (2005) 4695-4705
26. Ref. 7c describes the α-CT-catalysed hydrolysis of racemic 1 at pH 7.0, which furnished (S)-1 with 34% ee and after a conversion of 84%.
27. This sample was provided by AstraZeneca.